Innovative Pharmaceutical Biotech Limited filed its Annual on Jul 29, 2022 for the period ending Mar 31, 2022. In this report its auditor, Elite Partners CPA Limited, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Innovative Pharmaceutical Biotech Limited
Equities
399
BMG4783W1073
Industrial Machinery & Equipment
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.209 HKD | +2.45% | +0.48% | -4.57% |
May. 31 | Innovative Pharma Extends Long Stop Date for Convertible Bond Issuance | MT |
2023 | Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.57% | 45M | |
+10.40% | 44.18B | |
-0.37% | 36.23B | |
+10.31% | 7.22B | |
+18.20% | 6.98B | |
-15.86% | 4.69B | |
+21.55% | 1.47B | |
+9.01% | 1.46B | |
-0.89% | 1.45B | |
-3.56% | 981M |
- Stock Market
- Equities
- 399 Stock
- News Innovative Pharmaceutical Biotech Limited
- Innovative Pharmaceutical Biotech Limited Auditor Raises 'Going Concern' Doubt